title: [Some aspects of current treatment of patients with terminal chronic renal insufficiency].
abstract: Two groups of patients with terminal chronic renal failure (TCRF) treated from 1970 to 1979 (group 1) and in 1980-1989 (group 2) have been compared in respect to treatment results. All the patients underwent programmed hemodialysis performed on different equipment and according to different regimens. The results of group 2 appeared better: the lethality decreased by 18%, mean survival from 6 months to 4.5 years, up to half of the patients were able to receive hemodialysis procedures outpatiently, 30% of the patients were prepared to receive a renal transplant. The above positive shifts were achieved due to utilization of updated equipment, improved water purification, 3-stage technique of hemodialysis, antianemic drug eprex and vanalpha against osteodystrophy.
authors.forename: V I
authors.initials: VI
authors.lastname: Burtsev
authors.forename: V I
authors.initials: VI
authors.lastname: Grankin
authors.forename: A G
authors.initials: AG
authors.lastname: Briukhovetskiĭ
authors.forename: S A
authors.initials: SA
authors.lastname: Klopotskiĭ
authors.forename: E B
authors.initials: EB
authors.lastname: Miasnikova
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D016638:Critical Illness; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use*; D006435:Renal Dialysis; D015996:Survival Rate
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin
vernacular_title: O nekotorykh voprosakh sovremennogo lecheniia bolńykh s terminalńoĭ khronicheskoĭ pochechnoĭ nedostatochnostíu.